AHA 2019: French Registry Data Favor Edwards’ Sapien TAVR Over Medtronic’s CoreValve

The study’s authors say head-to-head randomized trials of the latest transcatheter aortic valves are urgently needed

Registry data from France shows transcatheter aortic valve replacement patients have better outcomes with Edwards’ Sapien balloon-expandable valves than with Medtronic’s CoreValve self-expanding valves.

MT1911_Doctor-heart_1547988785_1200.jpg
• Source: shutterstock.com

More from Clinical Trials

More from R&D